与使用处方药相关的急性心血管影响:丹麦全国查研究
Saad Hanif Abbasi1, Lars Christian Lund1, Jesper Hallas1,2
1Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense C, Denmark.
British journal of clinical pharmacology
|February 21, 2025
概括
这项研究对急性心血管风险的处方药进行了选,发现了常见药物类别和心房动和心脏病发作等疾病之间的联系. 需要进一步的研究来证实这些与药物相关的心血管事件关联.
科学领域:
- 心血管药理学心血管药理学
- 药理流行病学 药理流行病学
- 药物安全查 药物安全查
背景情况:
- 心血管疾病 (CVD) 构成了严重的公共卫生负担.
- 识别与处方药相关的急性心血管风险对于患者安全至关重要.
- 现有的研究往往侧重于特定的药物类别或结果,需要更广泛的查.
研究的目的:
- 为了进行对处方药的选,以产生对急性心血管影响的假设.
- 确定单个药物与主要心血管结果之间的潜在关联.
- 为未来有针对性的药物流行病学调查提供信息.
主要方法:
- 在丹麦,从2000年至2022年期间,采用了全国性的案例交叉研究设计.
- 分析了发生的心肌梗塞,缺血性中风,心力衰竭,静脉血栓栓塞,心肌炎和心房动的病例.
- 条件后勤回归与贝叶斯收缩被用来计算药物结果关联的几率比率.
主要成果:
- 包括超过190,000例心房动和145,000例心肌梗塞病例.
- 在6个心血管结局 (OR ≥1.5) 中,针对104种药物确定了222种关联.
- 抗生素,止痛药和皮质类固醇显示出一致的关联;潘托普拉和氧泽具有显著的特定风险.
结论:
- 该研究发现了处方药和急性心血管事件之间的许多潜在关联.
- 这些发现凸显了对特定药物类别和单个药物的进一步调查的需要.
- 结果为量身定制的药物流行病学分析提供了基础,以确认安全问题.
相关概念视频
01:16Antianginal Drugs: Nitrates and β-Blockers
497
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
497
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
522
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
522
01:22Heart Failure Drugs: β-Blockers
308
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
308
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
40
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
40
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371